Skip to main content
logo
Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China flag China · Delayed Price · Currency is CNY
2.820
-0.040 (-1.40%)
Sep 10, 2026, 3:04 PM CST

Huaren Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,3031,3211,3531,6361,6191,561
Revenue Growth
8.05%-2.34%-17.30%1.03%3.76%18.55%
Gross Profit
419.03457.04467.55695.83695.9760.15
Operating Income
114.25121.33130.05344.84244.58226.64
Net Income
-471.69-462.9-1,368188.06180.78130.4
Earnings Per Share
-0.40-0.39-1.160.160.150.11
EPS Growth
---3.99%39.09%37.50%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Industrial
1,2301,2701,4201,3041,257
High Levels
91.2383.49215.98315.88303.89
Total
1,3211,3531,6361,6191,561

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
212.74138.97163.81232.04221.71417.15
Total Debt
1,280931.361,2781,5641,6721,840
Net Cash (Debt)
-1,068-792.39-1,114-1,332-1,450-1,423
Net Cash Growth
------
Net Cash Per Share
-0.90-0.67-0.94-1.13-1.23-1.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
295.47390.23322.36305.6217.98-578.52
Capital Expenditures
-22.62-48.98-24.69-45.86-42.33-27.86
Free Cash Flow
272.85341.25297.67259.74175.65-606.38
Free Cash Flow Growth
-5.86%14.64%14.60%47.87%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
32.17%34.59%34.55%42.53%42.97%48.70%
Operating Margin
8.77%9.18%9.61%21.07%15.10%14.52%
Pretax Margin
-35.53%-34.73%-100.19%14.09%12.71%9.63%
Profit Margin
-36.21%-35.03%-101.13%11.49%11.16%8.36%
FCF Margin
20.95%25.82%22.00%15.87%10.85%-38.85%

Dividends
Chart
Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Jan '23 Jan '22
Dividend Per Share
0.0210.0210.018
Dividend Per Share Growth
0%16.67%20.00%
Dividend Yield
0.50%0.50%0.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---26.5327.7343.52
Forward PE
-41.1841.1841.1841.1841.18
P/FCF Ratio
12.3910.9113.9819.2128.54-
PS Ratio
2.602.823.083.053.103.64